About the Grant

The Retinal Medicine Clinical Research Award is an annual initiative sponsored by EURETINA to support and encourage independent clinical research in the field of retinal medicine.

Clinician or non-clinician researchers, in a hospital or laboratory-based setting may conduct several types of clinical research, such as observational research studies, register studies (patient or disease registry), natural history / epidemiological studies, phase IV studies (post-authorisation safety studies, “PASS”), genomic research studies, pharmacovigilance studies, retrospective case-control studies, systematic reviews, meta-analyses and several other types of clinical studies.

The maximum budget that can be requested is €300,000 for up to two years. Appropriate justification is essential.

The competition is open to all clinicians and researchers, who hold EURETINA membership on the closing date (1st Feb 2021) and have held continuous EURETINA membership since at least March 2020. Applicants must hold a full time clinical/research post at an EU-based clinical or academic research institute including H2020 associated countries*and the UK. Principal applicants and collaborators from industry are ineligible to apply. Please see further eligibility criteria below.

*(Iceland, Norway, Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro, Serbia, Turkey, Israel, Moldova, Switzerland, Faroe Islands, Ukraine, Tunisia, Georgia, Armenia)

The Purpose of the Award is:

    • To support, encourage and fund individuals that actively conduct clinical research in the field of retinal medicine.
    • To facilitate and support an independent culture of clinical study for the ultimate benefit of patients with retinal disease.
    • To engage and encourage the networking potential of the ophthalmic clinical community across the EU (and H2020 associated countries and the UK) to improve both patient care and outcomes.

Funding may be available over 2 years (maximum duration) for the right project with suitable infrastructure and experience.

2021 Call for Applications Now Closed.

Who is eligible?

    Applicants must

  • Hold a full time or affiliated post with an established EU-based (and H2020 associated countries and the UK) clinical or academic research institute
  • Be a clinician or researcher who holds EURETINA membership on the closing date (1st Feb 2021) and has held continuous EURETINA membership since at least March 2020 (obligatory for the Principal Applicant only).
  • Not be members of the EURETINA Executive, or Board Members (Please note that Board Members are permitted to be involved in a project as informal collaborators. Informal collaborators do not receive funding.)
  • Not have previously been awarded funding through the EURETINA Retinal Medicine Clinical Research Award Programme
  • Not have previously submitted an identical application for review in the EURETINA Retinal Medicine Clinical Research Award Programme
  • Have demonstrable prior experience in the conduct of clinical research in the field of retinal medicine and hold demonstrable GCP experience
  • Be familiar and experienced with the administrative, insurance and regulatory requirements for the conduct of EU-based clinical research studies

2020 EURETINA Clinical Research Award – Research Call Review Panel

Dr. Grazia PertileDr. Grazia Pertile ItalyChief of the Department of Ophthalmology, Sacrocuore Hospital, Negrar-Verona, Italy
Prof. Johannes R (Hans) VingerlingProf. Johannes R (Hans) Vingerling Netherlands Professor and Chair, Department of Ophthalmology, Erasmus Medical Center Rotterdam, The Netherlands
Prof. Ricarda G. SchumannProf. Ricarda G. Schumann Germany Professor of Ophthalmology, Vitreoretinal Surgery, University Eye Hospital Munich, Ludwig-Maximilians-University, Germany​
Professor Jerzy MackiewiczProf. Jerzy Mackiewicz Poland Head of Department, Department of Vitreoretinal Surgery, Medical University of Lublin, Poland

Schedule

Monday 1st February 2021 18.00 CET – Deadline for Expression of Interest
February/March – Panel review of eligible applications

How do I apply?

All eligible Expressions-of-Interest will be evaluated by the EURETINA Research Award Review Panel, from which short-listed entries will be invited to submit a full application.

Any queries prior to submission of an Expression-of-Interest application should be directed to research@euretina.org

Terms and Conditions

(a) I/we hold a full-time or affiliated post with an established EU-based (and H2020 associated countries and the UK) clinical or academic research institute, as named on my/our Expression-of-Interest submission.

(b) I/We have demonstrable prior experience in the conduct of clinical research in the field of retinal medicine and hold demonstrable GCP experience.

(c) I am/We are familiar and experienced with the administrative, insurance and regulatory requirements for the conduct of EU-based (and H2020 associated countries and the UK) clinical research studies.

(d) As Principal Applicant, I hold EURETINA membership on the closing date (1st Feb 2021) and have held continuous EURETINA membership since at least March 2020. My EURETINA membership number is included on my Expression-of-Interest submission.

(e) I/We understand that my/our Expression-of-Interest will be evaluated by the EURETINA Retinal Medicine Clinical Research Award Review panel, who will generate a short-list of applicants to be invited to submit a full application to EURETINA. All decisions on Expressions-of-Interest and short-listed proposals made by EURETINA shall be final and no correspondence shall be entered into in relation to decisions made.

(f) I/We understand that members of the EURETINA Executive and Board Members are not eligible to apply as Principal Applicants or formal collaborators. Board Members are permitted to be involved in a project as informal collaborators. Informal collaborators do not receive funding.

(g) I/We understand that awardees from previous rounds of the EURETINA Retinal Medicine Clinical Research Award Programme are not eligible to apply.

(h) I/We understand that resubmission of an identical application from previous rounds of the EURETINA Retinal Medicine Clinical Research Award Programme is not permitted.

(i) As Principal Applicant, I understand that I am eligible to submit only one Expression-of- Interest.

Applications Now Closed

Sign up to EURETINA


Loading please wait